Human immunodeficiency virus intra-host recombination has never been studied in vivo both during early infection and throughout disease progression. The CD8-depleted rhesus macaque model of neuroAIDS was used to investigate the impact of recombination from early infection up to the onset of neuropathology in animals inoculated with a simian immunodeficiency virus (SIV) swarm. Several lymphoid and non-lymphoid tissues were collected longitudinally at 21 days post-infection (p.i.), 61 days p.i. and necropsy (75-118 days p.i.) from four macaques that developed SIV-encephalitis or meningitis, as well as from two animals euthanized at 21 days p.i. The number of recombinant sequences and breakpoints in different tissues and over time from each primate were compared. Breakpoint locations were mapped onto predicted RNA and protein secondary structures. Recombinants were found at each time point and in each primate as early as 21 days p.i. No association was found between recombination rates and specific tissue of origin. Several identical breakpoints were identified in sequences derived from different tissues in the same primate and among different primates. Breakpoints predominantly mapped to unpaired nucleotides or pseudoknots in RNA secondary structures, and proximal to glycosylation sites and cysteine residues in protein sequences, suggesting selective advantage in the emergence of specific recombinant sequences. Results indicate that recombinant sequences can become fixed very early after infection with a heterogeneous viral swarm. Features of RNA and protein secondary structure appear to play a role in driving the production of recombinants and their selection in the rapid disease model of neuroAIDS.
INTRODUCTION
Human immunodeficiency virus (HIV) can exchange genetic segments between viral strains superinfecting the same host cell during reverse transcription, resulting in recombinant progeny (Levy et al., 2004; Salminen et al., 1995; Shriner et al., 2004) . Recombination in HIV-1 has been studied largely in the context of circulating recombinant forms of different viral subtypes that significantly increase global diversity (Gao et al., 1996; Kijak & McCutchan, 2005; Levy et al., 2004; Ng et al., 2011; Sabino et al., 1994) . However, intra-host recombination is also an important feature of viral evolution because of its ability to escalate viral diversity within circulating and tissueassociated HIV-1 subpopulations, influence the immune system's control of infection, and allow viruses to survive genomic damage (Coffin, 1979) . There is a general consensus that recombination in HIV-1 is quite common, with one study estimating two to three recombination events per genome per replication cycle (Jetzt et al., 2000) . Previous studies have also indicated that certain tissues, cellular subsets or disease processes can influence recombination rates (Lamers et al., 2009; Levy et al., 2004; Mild et al., 2007) . Intra-host recombination is more difficult to identify than recombination between subtypes because of the close evolutionary relationship between parental strains (Salemi Salminen et al., 1995) . Novel algorithms have recently been developed to address this problem (Delport et al., 2010; Huson & Bryant, 2006; Salminen et al., 1995) .
Recombination is the result of strand switching during reverse transcription in the virus life cycle. Three models may explain the production of recombinant viruses. In the 'forced-copy' model, reverse transcriptase continues elongation until it hits a break in the template that causes it to switch to another template (Coffin, 1979) . The 'copychoice' model emphasizes that specific sites for both donor and recipient templates stall RNA transcription, providing more favourable conditions for transfer to another virus (Negroni et al., 1995) . The 'dynamic copy-choice' model, an extension of the copy-choice model, proposes that the ratio of polymerase to RNase activity influences recombination rates, with increased recombination observed when strand extensions occur at a slower rate (Svarovskaia et al., 2000) . It is possible that all three models occur in nature and no study to date has shown one of these hypotheses to be prominent over the others.
Rhesus macaque (Macaca mulatta) models are useful surrogates in the study of infectious processes in human virus evolution. In particular, infection of the rhesus macaque with the simian immunodeficiency virus (SIV) causes a disease progression resembling that of humans infected with HIV-1 (Sellman & Lifson, 2001; Walshe et al., 1999; Williams & Burdo, 2012) . In previous studies, we used a CD8
+ T-cell-depleted macaque model to examine the section of virus during transmission of a pathogenic SIVmac251 viral swarm and early evolution of the virus (Strickland et al., 2011 (Strickland et al., , 2012 . In the present paper, we used sequence populations derived from these studies to examine the nature of early recombination events in six macaques. This is an accelerated disease model of neuroAIDS, in which unrestricted viral expansion occurs (Ratai et al., 2011; Williams & Burdo, 2012) , and generally results in meningitis and SIV-encephalitis (SIVE) within 65-120 days postinfection (p.i.) (Mankowski et al., 2002) . Alterations observed in this model of neuroAIDS are a consequence of unrestricted viral expansion in the setting of immunodeficiency rather than from CD8 + lymphocyte depletion alone (Burdo et al., 2010; Schmitz & Theres, 1999) . Whilst many previous studies have examined intra-host recombination rates and breakpoints during the chronic stage of HIV disease, in in vivo autopsy samples or in in vitro cell assays, the present study is the first to use the rhesus macaque model to observe recombination immediately after infection, during the initial viral expansion and longitudinally until the development of neurological disorders within many tissues.
RESULTS

Recombination rates
Recombinants were found at each time point in each macaque and detected as early as 21 days p.i. The mean percentage of recombinant sequences and the mean number of breakpoints did not significantly differ between macaques (data not shown). Using regression analysis as well as RECOMBINE, no statistical relevance could be established for an increase in recombination rates over time in any tissue group or across sampling time points. In all cases, RECOMBINE calculated a h of ,0.1, and in several instances h was ,0.01 and r was disproportionally high. Similarly, timeline plots for the number of recombinant sequences in different tissue groups over time in macaques D03, D04, D05 and D06 were quite different from each other and revealed no specific trend (Fig. S1 , available in JGV Online). Putative recombinant sequences were nonidentical to viral swarm sequences, indicating that they likely arose within macaques.
Recombinant breakpoints
Breakpoints were identified for sequences derived from each tissue at different time points using GARD (Table 1 , Fig. 1 ). GARD analysis revealed that identical putative breakpoints were found frequently in sequences derived from different tissues in the same macaque and further identical breakpoints were also found in sequences from different tissues in different macaques. In particular, five breakpoints occurred in multiple macaques: breakpoint 280, located in V1, was identified in D03, D04 and D05; breakpoint 355, located in V2, was identified in D03, D05 and D06; breakpoint 522, located in C2, was identified in D02 and D04; breakpoint 600, also located in C2, was identified in D01, D02, D03 and D04; breakpoint 859, located in V3, was identified in D05 and D06. Of these, breakpoint 280 was likely produced artificially by the removal of much of the V1 variable domain from the alignment before analysis and was excluded from further analysis. The C1-C2 domains contained a higher per cent of breakpoints than the V3-V4 domains in all macaques (Fig. 2) . The ratio of the number of breakpoints in the C1-C2 domain to the number of breakpoints in the V3-V4 domain ranged from 1.5 to 8.09 (D0152.33, D0252.03, D0358.09, D0454.88, D0552.13, D0651.50). A singlegenome sequencing (SGS) approach, used to determine if PCR artificially generated recombinant sequences, did not result in a statistically different number of recombinant sequences than found in our cloning experiments (P,0.05); in most cases, the results were quite similar, thus eliminating PCR as a source of recombinant sequences in our experiments.
SIV RNA and protein structures
Putative RNA secondary structures were inferred for all 1719 sequences in order to map the locations of breakpoints detected in multiple macaques (breakpoints 355, 522, 600 and 859). All structures were grouped and compared according to similarity (Figs 3 and 4 ; raw data are given in Tables S1-S3 ). Quite often, point mutations changed the minimum free energy (MFE) of the structures, but not the structures themselves; in these cases, a range of MFE scores is provided for each group. The calculated secondary structure for V2 was the most variable with eight diverse structures produced among isolates (each of these eight structures contained some minor differences). C2 produced two equally predominant structures. The stemloop RNA structure incorporating a partial V3 domain was highly conserved, appearing 90.34 % of the time in sequences from all macaques.
Fifty-six per cent of the nucleotides in both the V2 and C2 structures and 72 % of the nucleotides in the V3 structures were paired. Recombinant breakpoints in these structures always mapped to non-bonded nucleic acids in stemloops. Fig. 3(b) shows an example of two almost equally predominant structures calculated for C2, the locations of two persistent breakpoints and variable nucleic acid positions (red circles). A pseudoknot is formed in one of these MFE structures (yellow nucleotides).
Most of V1 was omitted from GARD analysis because detecting recombination is extremely difficult for regions with extensive length variation and homoplasy. In these cases, most algorithms produce a significant number of false positives (Posada & Crandall, 2001 ). However, we were interested in the impact of length variation on V1 RNA MFE structures. We show RNA structures for four sequences of variable V1 length (Fig. 4) . Three of these putative structures contained pseudoknots.
To test whether breakpoints may generate phenotypic diversity under positive selection, we also mapped breakpoints on a protein structure map (Fig. 5) . Recombinants that were fixed in the population contained breakpoints that mapped to regions that will code for N-linked glycosylation motifs (identified as NX [TS] , where X is any residue except proline) and disulfide bonds between cysteine residues in the structure. In all macaques, only four out of 20 recombination breakpoints found in 
DISCUSSION
Intra-host recombination during HIV/SIV infection plays an important role in shaping viral evolution, generating immune/drug escape variants (Coffin, 1995) and contributing to the emergence of viral subpopulations linked potentially to disease processes (Mild et al., 2007) . Previous studies have indicated that viral recombination rates could be associated with specific 'hotspots' in the genetic sequence (Archer et al., 2008; Baird et al., 2006) , as well as different rates of viral expansion (Lamers et al., 2009; Salemi et al., 2008) , disease progression (Lamers et al., 2009 ) and tissue pathology (Lamers et al., 2010) . However, no studies to date have assessed the impact of in vivo recombination on disease onset and/or progression by analysing longitudinal samples from early infection through terminal illness in different tissues. In HIVinfected subjects, such studies would obviously be difficult, if not unethical. In the present work, a rapid disease model of neuroAIDS was used to investigate for the first time the occurrence of recombination and the location of recombination breakpoints in different tissues over time from six macaques inoculated with the SIVmac251 viral swarm.
The depletion of CD8 in macaques within the first 12 days after infection results in the rapid development of simian AIDS (SAIDS) and elevated incidence of SIVE (Lifson et al., 2001b; , as well as a sustained higher plasma viral load during the asymptomatic period (Burdo et al., 2010; Wood et al., 2009) . As a result, a significant increase in the number of recombinant sequences might be expected in this model; however, no statistically significant increase in recombination rates within tissues over time could be detected in the present study. In a previous study, increased rates of HIV recombination were associated with diseased tissues at autopsy in patients with AIDS-related lymphoma and HIV-associated dementia (Lamers et al., 2009 ). Similar recombination rates found in all tissues in the current study could be due to the examination of recombination rates in early infection, rather than endstage disease. In addition, it cannot be excluded that this may be due to an insufficient number of sequences sampled. Alternatively, this finding could also be the result of the rapid emergence and fixation of recombinant sequences during early infection because of CD8 depletion, which results in poor immune control and an accelerated rate of progression to SAIDS and SIVE.
We also examined viral recombination in brain tissues and gp120 sequences isolated from SIV-infected monocyte/ macrophage (CD14) and T-cell (CD3) populations. Studies examining recombination in macrophages in vitro have suggested that increased recombination rates occur due to longer cellular life and more susceptibility to superinfection Early intra-host SIV recombination (Galiwango et al., 2011; Lamers et al., 2009; Swingler et al., 2007) . Additionally, in vivo, the continuous recruitment of macrophages at infection sites may also increase the possibility of superinfection (Lamers et al., 2009) . Others have suggested equal rates of recombination in both macrophage and T-cell populations (Chen et al., 2005) . The lack of cytotoxic T-cell control in our study could have fostered the expansion of macrophage-tropic and -neurotropic variants that would otherwise be cleared during early infection by the intact immune system of non-CD8-depleted macaques as well as limited expansion of T-cell tropic variants. In macaques D03 and D05 there were large fluctuations in the numbers of recombinant sequences detected over the time (Fig. S1 ). These two animals were diagnosed at necropsy with cytomegalovirus (CMV) coinfection. In humans, tissue macrophages co-infected with opportunistic pathogens such as Mycobacterium avium complex (MAC) or Pneumocystis carinii dramatically increase viral production and the likelihood of macrophage-mediated tissue destruction because they accelerate an already activated immune system (Orenstein et al., 1997) ; a similar mechanism may be in play with CMV-infected macaques, which could also impact recombination rates. However, D06, the macaque that lived the longest and with few infections, showed little change in overall recombination rate over time and the lowest ratio of C1-C2/V3-V4 . Evolutionary conserved breakpoints in SIV gp120. The secondary structure of the SIV gp120 protein was kindly provided by Brian T. Foley at the Los Alamos HIV Data Bank. A similar version was published previously (Hoxie, 1991) . Putative glycosylation sites are indicated by black dots. The black line in the V1 domain represents the length-variable region removed prior to analysis. Red crosses indicate identical recombination sites that were found among different primates. Blue crosses represent identical recombination sites found with individual primates.
breakpoints (Fig. 2) . In a study where recombinant breakpoints were calculated for six subjects at end-stage HIV disease using similar methods (Lamers et al., 2009 ), a much larger number of recombinant sequences were identified than were found at early-stage SIV disease; it is therefore also important to note that some differences between SIV evolution in the rapid macaque model for neuroAIDS and long-term in vivo HIV infection are expected to exist. Further studies contrasting a non-CD8-depleted SIV model with this study will clarify the effect of CD8 + T-cells on recombination rates in vivo.
RNA molecules form helical-like structures by pairing nucleotides, folding and thus lowering their MFE. Watts et al. (2009) generated a full-length HIV-1 RNA structure at a single-nucleotide resolution using SHAPE. They identified multiple conserved and independent RNA folding domains in the HIV-1 genome, including small stem-loops and larger, more complex folding structures. In addition, they found that variable regions of env, notably V1-V2, segregate from the rest of the protein and are flanked by structurally stable helices. They hypothesized that HIV-1 RNA is punctuated by numerous previously unrecognized regulatory motifs and that the extensive RNA structure may constitute an additional level of the genetic code, one we know little about. In light of this, it is interesting that we found variable, yet well-formed, RNA structures in the subregions of the three SIV envelope domains studied (V2, C2 and V3), each containing hotspots for recombination across multiple macaques. The breakpoints that were found in multiple macaques mapped to unpaired nucleotides within relatively stable secondary structures in the SIV gp120 sequences (Figs 3 and 4) . Therefore, point mutations that lead to unpaired bases in structures may influence strand switching during reverse transcription. While recombination may increase diversity at the genetic level, it may also increase diversity at the RNA structural level and allow structures to 'wobble' between different functional forms in successive replication cycles via the production of new structures containing new combinations of existing polymorphisms.
RNA folds are usually viewed as secondary structures; however, it is well known that three-dimensional (3D) RNA structures are much more complex than secondary structures and represent the RNA phenotype (Sperschneider & Datta, 2008) . These 3D RNA structures are involved in many activities, including structure-mediated regulation and catalysing reactions (Watts et al., 2009) . Pseudoknots are functionally diverse, an important structural feature of viral RNAs, and involve the pairing of bases in a hairpin loop with bases outside the stem of the loop to form a second stem and loop region (Chen et al., 1992; Liu et al., 2010; Wills et al., 1994) . These are usually ignored in computational prediction algorithms for reasons of computational efficiency; however, one of the folding algorithms used in this study, PKNOTSRG, overcomes this hurdle when folding small to moderately sized RNA sequences (Reeder et al., 2007) with the incorporation of a recursive folding method. In our studies, we found that with only two nucleic acid differences between sequences, 48 % of the C2 MFE structures contained putative pseudoknots (Fig. 3b) . While C2 breakpoint 600 does not appear to be associated with any pseudoknot bonds, breakpoint 522 is bonded and located at the beginning of the calculated pseudoknot. One of these structures may be more prone to recombination, whereas the other may be more prone to slipping. Moreover, in light of this, it is interesting that V1-C3, a region with many calculated pseudoknots, contained a much higher number of recombination breakpoints than V3-V4, a region with no calculated pseudoknots.
One of the major known functions of pseudoknots in retroviruses is ribosomal frame shifting, which is critical when encoding two proteins within one genomic region (i.e. gag-pol). However, in the context of the HIV/SIV envelope, it is possible that pseudoknots could work in-frame to increase diversity by promoting recombination or inducing transcriptional slips. For example, HIV/SIV envelope variable . Model for pseudoknot-driven copy-choice recombination and generation of indels. Copy-choice recombination models state that recombination is due to reverse transcription slowing down at certain structural regions of RNA that can lead to strand switching. We propose that pseudoknots, along with other structural features, can also slow down reverse transcription. Additionally, pseudoknots may result in slipping during reverse transcription, thus leading to insertions or deletions, especially in the variable regions of gp120.
domains, especially V1 and V4, can gain or lose short strings of nucleic acids in successive rounds of replication that will eventually encode glycosylation sites (Lamers et al., 1996; Simmonds et al., 1990) . If pseudoknots are capable of stimulating frame shifts through a programmed slippery site in the RNA to produce gag-pol (Baril et al., 2003) , perhaps pseudoknots within the HIV-1 envelope also stimulate viral diversity through a mechanism of unprogrammed ribosomal frame shifts that could result in insertions and/or deletions in gp120 sequences. In support of this hypothesis we show four MFE structures produced in PKNOTSRG that encompass the V1 domain for a single SIV-infected macaque, which is the region displaying most length variation in the SIV envelope in our sequence population (Fig. 4) . Three of these MFE structures contained different putative pseudoknots, whilst the fourth contained none. Pseudoknots could trigger recombination by slowing translation in specific regions as described in the dynamic choice-copy model of recombination or, alternatively, recombination could move viral segments to promote pseudoknot formation. Moreover, there may be some interplay between point mutations and pseudoknot formation. For example, point mutations could alter the shape of RNA structure and perhaps lead to the formation of small pseudoknots. Pseudoknots may also result in the generation of indels in the SIV/HIV gp120 sequences during reverse transcription (Fig. 6) . Although pseudoknot formation in gp120 variable loops will need to be proven experimentally, we may find that pseudoknots in the variable envelope domains are as important as recombination and point mutations in driving diversity in the HIV glycoprotein. This premise can be further explored as computational algorithms for determining RNA secondary and tertiary structures continue to advance.
Frequently, recombinant breakpoints in protein sequences were shared among different macaques and mapped to amino acid motifs that will code for N-linked glycosylation motifs or at the sites of cysteine residues in the SIV glycoprotein, thus suggesting a selective advantage for recombination events occurring at these known structural motifs in HIV glycoproteins. Moreover, since the animals were CD8 depleted, there are clearly factors other than the Tcell response that drive viral selection. These factors may include macrophage-specific immune responses or unknown RNA structural features that provide increased infectivity, thus resulting in their early establishment in the population.
In conclusion, the identification of recombinant sequences in all examined tissues and in multiple CD8-depleted macaques as early as 21 days p.i., as well as their persistence over time, emphasizes the importance of SIV intra-host recombination in the rapid model of neuroAIDS. Whilst use of the CD8-depleted macaque model may not completely capture all aspects of recombination during early infection, it demonstrates that features other than T-cells drive viral evolution. Importantly, the rapid model of AIDS is relevant to HIV infection in humans, especially when considering macrophage reservoirs. The analysis of recombination patterns in SIV-infected but non-CD8-depleted animals that follow a natural course of infection is currently under way, and may shed further light on the interplay between immune control and the emergence and fixation of recombinants and the development of SIVE.
METHODS
Study population. The inoculating viral swarm for the macaques was described previously by Strickland et al. (2011) . The macaque study population, sampling and sequence amplification strategy have also been described previously in detail by Strickland et al. (2012) . Briefly, subjects D01 and D02 were euthanized at 21 days p.i. when SIV infection was well-established, animal D03 was euthanized at 75 days p.i. due to severe weight loss and cytomegalovirus (CMV) coinfection, animal D04 was euthanized at 91 days p.i. due to severe encephalitis, animal D05 was euthanized at 95 days p.i. due to a rapid physical decline and co-infection with CMV, and animal D06 was euthanized at 118 days p.i. due to brain haemorrhage. Post-mortem pathology reports showed that D03-D05 all developed SIVE, while D06 had severe meningitis. Plasma and tissue samples were collected from macaques D01 and D02 at 21 days p.i., while samples from the other primates were collected at three time points (T 1 521 days p.i., T 2 561 days p.i., T 3 575-118 days p.i.). A total of 1717 SIV gp120 V1-V4 RNA sequences (SMM239 coordinates 6706-8049) from all macaques were generated and aligned; the alignment was further modified by hand to optimize insertions and deletions within the variable domains (Lamers et al., 1996) . Most of the V1 domain was removed due to a high degree of length variation that could influence recombination calculations (Posada & Crandall, 2001; Salemi et al., 2009) . The sequences have been submitted to GenBank (accession numbers JF764947-JF766081 and JQ608488-JQ609071), and alignments are available from the authors upon request.
Recombination analysis. Recombination analysis was carried out for sequence populations in each tissue and in each macaque using three methods: (1) GARD (http://www.datamonkey.org/), a phylogenetic method that uses maximum-likelihood partition of the alignment into segments with different evolutionary histories to estimate recombinant breakpoints in each alignment (Delport et al., 2010) , (2) an algorithm that uses split decomposition networks in combination with the 'phi-test' (Bruen et al., 2006; Salemi et al., 2008) implemented in SPLITSTREE4 software (Huson, 1998 ) calibrated specifically to identify likely recombinants within intra-host viral populations (Galiwango et al., 2011; Lamers et al., 2009; Salemi et al., 2008) , and (3) RECOMBINE, a program that makes a maximumlikelihood estimate of per-site recombination via the calculation of h (the product of the effective population size and neutral mutation rate per site) and r (the ratio between per-site recombination rate and per-site mutation rate) (Kuhner et al., 2000) . RECOMBINE parameters were estimated by sampling over numerous recombinant genealogies in proportion to each genealogy's expected contribution. RECOMBINE calculates lower estimates of r than pairwise methods; however, when h,0.10, there is a pronounced upward bias in r. Recombinant sequences were also identified using bootscanning [implemented in SIMPLOT (Lifson et al., 2001a) and RDP (Crotty et al., 2001) ] with observed trends similar to those obtained with the algorithms listed above (data not shown). Putative recombinant sequences, identified with SPLITSTREE4, were screened against viral swarm sequences in order to determine if they originated from the inoculum.
A binomial-probit regression model was used to determine whether an increase in the number of recombinants (calculated with SPLITSTREE4) or breakpoints (calculated with GARD) occurred over time, with the number of sequences as a random effect. Tissues were then grouped according to several types: (1) peripheral blood T-cells (CD3 + cells), (2) peripheral blood monocytes (CD14 + cells), (3) monocyte/macrophage-infiltrated tissues (meninges, frontal lobe, parietal cortex, temporal lobe and bronchial lavage) and (4) mixed tissues (plasma, bone marrow and lymph node). The percentage of recombinants for each tissue group was also plotted over time.
Breakpoints estimated by GARD for each tissue and at each time point were mapped to a consensus SIVmac251 sequence. The ratio of the number of breakpoints within the C1-C2 domains was compared to the V3-V4 domain for each macaque. When multiple tissues contained the same breakpoint, it was mapped to the SIV RNA secondary structure map.
To test if recombinants were generated artificially during PCR, we performed multiple replicate cloning and SGS experiments applied to cDNA from SIV derived from macaque plasma samples. SGS allows for direct sequencing of a PCR product that is generated from a single cDNA template, thus eliminating the possibility of PCR-mediated recombination (Palmer et al., 2005) . The cloning experiments used SIV-specific primers and a protocol described previously (Palmer et al., 2005; Strickland et al., 2011) . Two plasma samples with a high number and two with a low number of calculated recombinant sequences were used in three separate replicate amplifications for both cloning and SGS methods. For each of the four samples tested, the numbers of recombinants was determined using the 'phi-test' as implemented in SPLITSTREE4 from three cloning and three SGS replicates per sample. The numbers of recombinant sequences produced for each method were then compared using x 2 -tests with a cut-off P-value of 0.05.
RNA structures. Putative RNA substructures within the gp120 sequences were generated for mapping recombinant breakpoints found in multiple macaques using PKNOTSRG, an algorithm that employs Turner energy rules and predicts the energetically best RNA secondary structure (lowest MFE), including structures containing pseudoknots. If pseudoknots were not predicted, the resulting structure prediction was identical to the MFE structure computed by the RNAFOLD package (http://rna.tbi. univie.ac.at/cgi-bin/RNAfold.cgi). RNAFOLD computes structures and measures three energies across the length of the protein: MFE using dynamic programming (Zuker & Stiegler, 1981) , John McCaskill's partition function (PF) algorithm (Gruber et al., 2008) and centroids in a Boltzmann weighted ensemble (Ding et al., 2005) . RNA structures for all non-identical V2 (SMM239 coordinates 7036-7158), C2 (SMM239 coordinates 7234-7401) and V3 (SMM239 coordinates 7563-7639) sequences were generated using the BibiServ PKNOTSRG server (http:// bibiserv.techfak.uni-bielefeld.de/pknotsrg) (Reeder et al., 2007) .
To determine if pseudoknot formation might impact length variation in glycosylated variable regions, we also calculated four SIV V1 RNA structures using PKNOTSRG. The sequences were selected based on nucleic acid length variation.
